PMCCPMCCPMCC

Search tips
Search criteria 

Advanced

Logo of plosonePLoS OneView this ArticleSubmit to PLoSGet E-mail AlertsContact UsPublic Library of Science (PLoS)
 
From:
Published online 2017 April 5. doi: 10.1371/journal.pone.0173777

Table 4

Patient characteristics; excluding Sapien 1 valves.
Clinical VariableTotal, n = 139General, n = 90Sedation, n = 49P-value
Age, mean (SD), years82.1 ± 1181.3 ± 1283.5 ± 90.23
Male, No. (%)72 (52)46 (51)26 (53)0.83
BMI, mean (SD), kg/m227.5 ± 627.6 ± 727.3 ± 50.75
NYHA class, No. (%)0.17
Class 114 (10.1)10 (11.1)4 (8.2)
Class 250 (36.0)34 (37.8)16 (32.6)
Class 365 (46.8)37 (41.1)28 (57.1)
Class 410 (7.2)9 (10)1 (2)
STS Risk, Mort % (SD)7.2 ± 57.2 ± 47.2 ± 60.95
Hypertension, No. (%)112 (80.6)74 (82.2)38 (77.6)0.52
Afib/Aflutter, No. (%)50 (36.0)35 (38.9)15 (30.6)0.33
Diabetes mellitus, No. (%)45 (32.3)34 (37.8)11 (22.4)0.06
Prior MI, No. (%)52 (37.4)38 (42.2)14 (28.6)0.11
PAD, No (%)19 (13.4)12 (13.3)7 (14.3)0.89
Hemoglobin, mean% (SD)11.8 ± 2.411.6 ± 2.412.3 ± 2.10.07
Renal Status, No. (%)0.50
Normal (Cr<2.0)125 (89.9)82 (91.1)43 (87.8)
Insufficiency (Cr≥2, not on dialysis)9 (6.5)6 (6.7)3 (6.1)
Failure (dialysis)5 (3.6)2 (2.2)3 (6.1)
Hx stroke or TIA, No. (%)24 (17.3)16 (17.8)8 (16.3)0.83
LVEF, mean (SD)54.1 ± 1653.2 ± 1755.7 ± 140.35
KCCQ Score49 ± 2649 ± 2650 ± 270.85
Approach, No. (%)<0.001*
Transfemoral109 (78.4)60 (66.7)49 (100)
Transapical30 (21.6)30 (33.3)0 (0)
Valve Type, No. (%)<0.001*
Sapien XT65 (46.8)65 (44.2)0 (0)
Sapien 374 (53.2)25 (17.0)49 (100)

BMI, body-mass-index; NYHA, New York Heart Association; STS, Society of Thoracic Surgeons; Mort, mortality risk; Afib/Aflutter, atrial fibrillation or atrial flutter; MI, myocardial infarction; PAD, peripheral vascular disease; TIA, transient ischemic attack; LVEF, left ventricular ejection fraction; KCCQ, Kansas City Cardiomyopathy Questionnaire

* = statistically significant